Loading clinical trials...
Loading clinical trials...
A Phase I, Open-label, Safety Study of Anti-inflammatory Therapy With Rilonacept in Adolescents and Adults With Type 1 Diabetes Mellitus
This study is being done to see if an investigational drug called rilonacept is safe to use in patients with type 1 diabetes, and if it can slow the loss of the body's ability to secrete insulin in patients who are still able to make a small amount of insulin.
Age
16 - 45 years
Sex
ALL
Healthy Volunteers
No
Children's Medical Center
Dallas, Texas, United States
Start Date
February 1, 2011
Primary Completion Date
March 1, 2013
Completion Date
June 1, 2013
Last Updated
February 24, 2014
13
ACTUAL participants
Rilonacept
DRUG
Lead Sponsor
University of Texas Southwestern Medical Center
NCT07051005
NCT06390371
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT03228732